Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
Read Now: Expert Opinions on HIV Cure Research
  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

  

What's New at The Body

HIV/AIDS News You Can Use

October 3, 2001

Youth Prevention Guide

What works in HIV prevention for youth? Browse through AIDS Action's comprehensive brochure with reports on what is working in local communities and what prevention science research says works.

The Effect of September 11 on AIDS Organizations

"Several major AIDS organizations in Manhattan were in the disaster area near the World Trade Center. It appears that everyone in those offices got out alive, although some lost friends or relatives.The long-term consequences for the global fight against AIDS, tuberculosis, malaria, and other major infectious diseases remain unknown but ominous." The effect of the September 11th tragedy on the AIDS pandemic, by John James, in AIDS Treatment News.

Prevention for Positives

Many folks view HIV as a "manageable disease." As my good friend Scott says (referring to the side effects from his HAART regimen), "I don't think there is anything manageable about crapping on myself!" I think Scott speaks for most of us who have been on meds -- there is still nothing manageable about it! Cathy Olufs discusses prevention for positives and other topics, in Women Alive.

Proposal on Global Medicine Access

At a recent meeting in Geneva on access to medicines, 52 developing countries asked the members of the World Trade Organization to agree that rules on international patent protection (known as TRIPS) be interpreted in ways that allow governments to ensure access to affordable medicines.

The Truth About Drug R And D

The pharmaceutical industry's trade group, Pharmaceutical Research and Manufacturers of America (PhRMA), has long maintained that developing a single new drug and bringing it to market takes on average 12-15 years and costs $500 million. A new report by Public Citizen, a consumer group founded by Ralph Nader, estimates the pre-tax cost of bringing a new drug to market during the nineties was only about $107M." Which is true? Check out Bob Huff's article, "What Does R&D Really Cost?" in GMHC's Treatment News.

Screening Plasma for HIV and Hepatitis

FDA approves the first nucleic acid test (NAT) systems to screen plasma for HIV and hepatitis C. For the details, click here.

HPV in Women with HIV

High-risk human papillomavirus infections and squamous intraepithelial lesions persist in many HIV-infected women despite highly active antiretroviral therapy (HAART), researchers reported in the Journal of Infectious Diseases in September.

Getting Pregnant When You're HIV Positive

If you are pregnant or thinking about becoming pregnant and you are HIV positive, here are some guidelines recommended by the Department of Health and Human Services explained in Women Alive.

Newly Diagnosed?

Brenda Calderon offers suggestions on how to overcome the fear and shame that many people feel when an HIV test comes back positive, in Women Alive.

October Web Gallery

The October Visual AIDS Web gallery is now live! Click here and browse through the fascinating work of Visual AIDS archive members Barton Lidice Benes, Robert Blanchon, Valerie Caris, Jimmy DeSana, Enrico Filippi, Felix Gonzalez-Torres, Rene Santos, Hugh Steers, Steed Taylor and Tseng Kwong Chi.

National Call to Commitment

AIDS activists typically spend September and October in the middle of appropriations battles, working hard to ensure that Congress approves the highest possible funding levels for critical HIV/AIDS programs. The week of October 1st is National Call to Commitment Week for AIDS funding. Click here to find out more.

Dr. Jeffrey Laurence Interviewed

"It's very difficult to change people's behaviors, and a vaccine is going to be a long time coming, so we need to do the next best thing. This is something I describe as a 'chemical condom'. . . . As you use spermicides to kill sperm, you would use these microbicides, as they're known, to kill viruses." An interview with Dr. Jeffrey Laurence, from amfAR.

The Lottery vs. Finding AIDS Cure

"When I play a buck on the lottery and don't win, I feel sad. So I stay away from the lottery. I feel sad thinking about a cure, because I just don't see it happening, just like I don't see my buck becoming ten million." Jim Pickett muses on stopping treatment, safe sex, and a cure for AIDS, in Positively Aware.

Opportunistic Infections 101

"An opportunist: someone who takes advantage of you. Well, that's what an opportunistic infection is -- one that waits until your immune system is weak so it can prey on you." Opportunistic Infections 101 by Enid Vázquez, in Positively Aware.

Demise of Remune

Martin Delaney, the founding director of Project Inform, says the demise of the experimental HIV treatment called Remune is long overdue. The therapeutic vaccine for HIV (meant to control disease progression, not to prevent infection) has shown disappointing results from its beginning. Read why Remune will bite the dust . . . again, in Positively Aware.

Progress in Fighting AIDS Over?

"The latest data suggest that the era of dramatic declines is over [and] there are a number of signs indicating that our progress in fighting the disease is in serious jeopardy," said outgoing CDC Director Helen Gayle. Click here to read details on this.

Dr. Krim on AIDS Denialists

We've ignored them for too long -- now Dr. Mathilde Krim, amfAR's Founding Chairman and Chairman of the Board, joins the overwhelming majority of knowledgeable AIDS specialists offering a clear and compelling response to the small but vocal group of AIDS denialists who argue -- incorrectly -- that HIV does not cause AIDS.

Web Highlights
A Selection of the Top HIV/AIDS Stories from Across the Internet

Baby Born After HIV Taken from Sperm
From The Japan Times (October 3, 2001)

Brazilian Women Ravaged By AIDS
From the Washington Post (September 30, 2001)

  





  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

 

Tools
 

Advertisement